Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N,N′-di-1 naphthylguanidine HCl (NAGH) and N,N′-di-p-nitrophenylguanidine HCl (NAD) treatment for stroke at delayed timepoints

N,N′-di-1 naphthylguanidine HCl (NAGH) and N,N′-di-p-nitrophenylguanidine HCl (NAD) treatment for stroke at delayed timepoints

US Patent 9636311 · Granted May 2, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Machine learning algorithm for predicting clinical outcomes and identifying drug2025
Ischemic tissue cell therapy2019
Compositions and methods for treating stroke2019
Afobazole nanoparticles formulation for enhanced therapeutics2019
Human cord blood as a source of neural tissue repair of the brain and spinal cor2017
Use of endogenous antioxidant proteins in the treatment of stroke2017
Use of endogenous antioxidant proteins in the treatment of stroke2017
Microfluidic device for generating neural cells to simulate post-stroke conditio2017
Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds2015
Microfluidic device for generating neural cells to simulate post-stroke conditio2014
Ischemic tissue cell therapy2014
Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase2014